Press Room

Press Releases

May 12, 2011
NB Therapeutics Appoints Jeff O'Donnell as Chairman Of The Board

January 5, 2011
NB Therapeutics Completes Enrollment in Phase 2 Onychomycosis Study

July 15, 2010
Nitric BioTherapeutics Initiates Phase II Onychomycosis Study Appoints Al Altomari as Executive Chairman of the Board and Announces Closing of Financing Round

December 10, 2009
Nitric BioTherapeutics Acquires New Technology Platform and Clinical Development Programs from Transport Pharmaceuticals

June 18, 2009
Nitric BioTherapeutics, Inc. President Frank J. McCaney named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Philadelphia

November 11, 2008
Nitric Biotherapeutics Hires David Pfeiffer as Chief Operating Officer

March 13, 2008
Nitric Biotherapeutics Launches Phase II Clinical Trial for the use of Nitric Oxide in the Healing of Chronic Wounds

February 12, 2008
Nitric Biotherapeutics Hires Joel Lippman, M.D. as GM of its Antimicrobial Business

December 6, 2006
NitricBio Chosen as 2006 Company to Watch